Evidence-based Nomenclature and Taxonomy of Research Impact Indicators
, oraz
03 lip 2020
O artykule
Kategoria artykułu: Research Paper
Data publikacji: 03 lip 2020
Zakres stron: 33 - 56
Otrzymano: 28 sty 2020
Przyjęty: 20 maj 2020
DOI: https://doi.org/10.2478/jdis-2020-0018
Słowa kluczowe
© 2020 Mudassar Arsalan et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1

Figure 2

Nomenclature of Indicator with Examples_
Functions (F) |
Improvement / Addition / Reduction |
Creation |
Recognition |
Obsoleting / Replacing |
Context (C) |
Target (t) |
Domain (d) |
j_jdis-2020-0018_apptab_001_w2aab3b7c20b1b6b1ab2b2ab2Aa
Ref | Indicator | Reference | Measure | Qualitative/Quantitative |
---|---|---|---|---|
1 | Identification of research gaps, questions and new research dimension | ( | Yes / No | Qualitative |
2 | Development of a new technique for data collection and new data | ( | Yes / No | Qualitative |
3 | Creation of a research method or extension of existing by involving new approach and technique | ( | Yes / No | Qualitative |
4 | Defining the concept and subject vocabulary in a more comprehensive way | ( | Yes / No | Qualitative |
5 | Formation of research groups and collaborate in multidimensional research | ( | Yes / No | Qualitative |
6 | Recruitment of skilled researchers | ../../../../Google Drive/Working/001 PhD Work/00103 Paper 1/Drafting/Indicators v2.xlsx - RANGE!_ENREF_68 ( | How many researchers are recruited? | Quantitative |
7 | Development of communities of science, new grant programmes; replication and new research | ( | Yes / No | Mixed |
8 | Effective planning and addressing future research | ../../../../Google Drive/Working/001 PhD Work/00103 Paper 1/Drafting/Indicators v2.xlsx - RANGE!_ENREF_51 ( | Yes / No | Qualitative |
9 | Research capacity building for an individual or a group of researchers | ( | How many researchers are trained? | Quantitative |
10 | Preparing a better procedure for researchers induction | ( | Yes / No | Qualitative |
11 | Improvement in ethical approval processes for better decisions and timeliness | ( | Yes / No | Qualitative |
12 | Formation of new research teams and projects | ( | How many projects and teams are established? | Quantitative |
13 | Successful completion of ongoing research with the achievement of set targets | ( | Yes / No | Mixed |
14 | Retention of research team by involving in productivity and future research | ( | How many members are retained? | Quantitative |
15 | Advancement in numbers and quality of research and research teams | ( | Yes / No | Mixed |
16 | Enhancement of research process, behaviour and procedural protocols | ( | Yes / No | Qualitative |
17 | Recognition and leadership of researchers in the research domain | ( | Yes / No | Qualitative |
18 | Improvement of research communication between researchers and research organizations | ( | Yes / No | Qualitative |
19 | Serving of research staff on a higher level in more advanced organizations at national and international level | ( | Yes / No | Qualitative |
20 | Improvement in research culture and overall environment | ( | Yes / No | Qualitative |
21 | Identification and overcoming of the research process constraints | ( | Yes / No | Qualitative |
22 | Improved willingness and tangible measures for practice-based and applied research | ( | Yes / No | Qualitative |
23 | Development of improved analytical methods for existing data | ( | Yes / No | Qualitative |
24 | Improvement in multi-disciplinary research methods | ( | Yes / No | Qualitative |
25 | Creation of methods for cross domains results in interpretation and synthesis | ( | Yes / No | Qualitative |
26 | Embracing the innovative methods for measuring the research outcome | ( | Yes / No | Qualitative |
27 | Discovery of new or advanced research findings | ( | Yes / No | Qualitative |
28 | Discovery of novel knowledge or innovative techniques | ( | Yes / No | Qualitative |
29 | Demonstration of an efficient way of treatment | ( | Yes / No | Qualitative |
30 | Development of new research devices or products for better results | ( | Yes / No | Mixed |
31 | Obtaining patents for new devices or products | ( | How many patents are obtained? | Quantitative |
32 | Identification or validation of new biomarkers for better healthcare | ( | Yes / No | Qualitative |
33 | Use of research outcomes and discoveries into the advancement of research related to animals and humans | ( | Yes / No | Qualitative |
34 | Receiving an award on research | ( | How many awards are received? | Quantitative |
35 | The increment in number and proportion of research grant submissions and awards | ( | What is the proportion of success of grant award? | Quantitative |
36 | Increase in the quantity of publications in high ranking journals as a research outcome | ( | How many publications are produced in high ranking journals? | Quantitative |
37 | Increase in the total impact factor gained by publishing research in high ranking journals | ( | How much impact factor is gained? | Quantitative |
38 | Increase in the conference papers and presentations organized on national or international levels. | ( | How many conference papers and presentations are produced? | Quantitative |
39 | Increase in the number of citations of research outcome | ( | How many citations are obtained? | Quantitative |
40 | Increase in media appearance of researchers or research organizations for their findings and its relation to the public | ( | How many times appeared in media? | Quantitative |
41 | Popularity and acceptance of research-based knowledge and techniques in masses (e.g. change in community-based health practice or education system) | ( | Yes / No | Qualitative |
42 | Participation of researchers as a member of the research journal editorial board or become a journal editor | ( | Yes / No | Qualitative |
43 | Dissemination and reach of research outcome to more audiences | ( | Yes / No | Qualitative |
44 | IF2-Index | ( | Index Value | Quantitative |
45 | h-Index | ( | Index Value | Quantitative |
46 | Contemporary h-Index | ( | Index Value | Quantitative |
47 | Individual h-Index | ( | Index Value | Quantitative |
48 | Hi-Index | ( | Index Value | Quantitative |
49 | H2-Index | ( | Index Value | Quantitative |
50 | M-Quotient | ( | Index Value | Quantitative |
51 | G-Index | ( | Index Value | Quantitative |
52 | Y-Index | ( | Index Value | Quantitative |
53 | PRP-Index | ( | Index Value | Quantitative |
54 | IFQ2A index | ( | Index Value | Quantitative |
55 | DCI-Index | ( | Index Value | Quantitative |
56 | R-& AR-Indices | ( | Index Value | Quantitative |
57 | AHP Index | ( | Index Value | Quantitative |
58 | Altmetric | ( | Altmetric Attention Score | Quantitative |
59 | STAR Metrics | ( | Index Value | Quantitative |
60 | ResearchGate-Score | ( | Index Value | Quantitative |
61 | Crown indicator | ( | Index Value | Quantitative |
62 | Societal Quality Score | ( | Index Value | Quantitative |
63 | PlumX Metrics | ( | Index Value | Quantitative |
64 | Positive reviews of creative publications and performances | ( | Yes / No | Qualitative |
65 | Non-academic publications in government reports | ( | How many publications are done in government reports? | Quantitative |
66 | Non-academic citations in government reports | ( | How many citations are made in government reports? | Quantitative |
67 | Number of industrial contracts | ( | How many industrial contracts are obtained? | Quantitative |
68 | Amount of industrial and academic funding | ( | How much funding is secured? | Quantitative |
69 | Community awareness of research; Collaborative projects with end users | ( | Yes / No | Qualitative |
70 | Facilitation and participation in expert panels for research enquiries; external institution; steering committees and advisory boards | ( | Yes / No | Mixed |
71 | Use of research outcomes, discoveries or clinical trials as a best practice | ( | Yes / No | Qualitative |
72 | Use of research outcome in efficiency and better performance of services | ( | Yes / No | Qualitative |
73 | Provision of diversified and efficient intervention and treatment options for clinicians | ( | Yes / No | Qualitative |
74 | Improved client care | ( | Yes / No | Qualitative |
75 | The decrease in events of work-environment mistakes | ( | What is the decrease rate of work-environment mistakes? | Quantitative |
76 | Increase in the provision of training of healthcare improvement from the healthcare providers to the support staff | ( | How many support staff are trained? | Quantitative |
77 | Improvement in technologies and information systems for social applications | ( | Yes / No | Qualitative |
78 | Increase in training development for system improvement | ( | How many trainings are developed for healthcare improvements? | Quantitative |
79 | Creation of prevention methods for clinical practice | ( | Yes / No | Qualitative |
80 | Adapting evidence-based practices | ( | Yes / No | Qualitative |
81 | Improvement in patient outcomes | ( | Yes / No | Qualitative |
82 | Improvement in health behaviours enthusiasm of patients and general masses | ( | Yes / No | Qualitative |
83 | Development and promulgation of guidelines and policies | ( | Yes / No | Qualitative |
84 | Progress in personal circumstances-based healthcare e.g. based on genetic sequencing | ( | Yes / No | Qualitative |
85 | Strengthening of service-client relationship | ( | Yes / No | Qualitative |
86 | Research outcome translation into medical practice for improvement | ( | Yes / No | Qualitative |
87 | Strengthening human protection through improved policies and better procedures | ( | Yes / No | Qualitative |
88 | Improvement in regulation for introducing advanced technologies, tools and techniques | ( | Yes / No | Qualitative |
89 | Compliance of ethical guidelines in research | ( | Yes / No | Qualitative |
90 | Development of community-based awareness | ( | Yes / No | Qualitative |
91 | Betterment of policies, guidelines and reimbursement systems for service providers | ( | Yes / No | Qualitative |
92 | Increased empowerment of service users | ( | Yes / No | Qualitative |
93 | Support of research outcome and information for political decision and policy-making | ( | Yes / No | Qualitative |
94 | Improved public awareness about the environment and culture, Public behaviour change and advocacy; Increased literacy and numeracy rates | ( | Yes / No | Qualitative |
95 | Improvement in health literacy of health users and patients | ( | Yes / No | Qualitative |
96 | Improvement in health status of health users and patients | ( | Yes / No | Qualitative |
97 | Establishment of public health, education or any other social schemes for a region | ( | Yes / No | Qualitative |
98 | The decrease in social disparities | ( | Yes / No | Qualitative |
99 | Improvement in inter-organizational coordination for betterment in social sector | ( | Yes / No | Qualitative |
100 | Increase in planning efforts and program implementation related to social issues | ( | Yes / No | Qualitative |
101 | Improvement in health user about health research | ( | Yes / No | Qualitative |
102 | Increased empowerment and knowledge of health users about health issues | ( | Yes / No | Qualitative |
103 | Better communication and perception of health users about health risks | ( | Yes / No | Qualitative |
104 | Expansion of health education, literacy and other social advantages | ( | Yes / No | Qualitative |
105 | Improvement in Occupational Health and Safety Environment | ( | Yes / No | Qualitative |
106 | Disuse the law for obsoleting the existing method of drug approval | ( | Yes / No | Qualitative |
107 | Commercialization of new discovery, product or technology | ( | Yes / No | Qualitative |
108 | Improvement in cost reducing techniques and effectiveness | ( | Yes / No | Qualitative |
109 | Improvement in economic gains such as increased employment, health cost cut | ( | Yes / No | Mixed |
110 | Development of new job opportunities and growth in the specific economic sector or geographical region | ( | Yes / No | Mixed |
111 | Development of medicinal products and therapeutic procedures | ( | How many products or procedures are developed? | Quantitative |
112 | Improvement in a business environment, commercialization, technology incubation, products and processes | ( | Yes / No | Qualitative |
113 | Reduction in work loss due to illness and increased benefits from a healthy workforce | ( | Yes / No | Qualitative |
114 | Increased Royalties, employment, Licences; creative works commissioned | ( | Yes / No | Mixed |
115 | Creation of new knowledge about sustainable development and environmental protection for better future of the world | ( | Yes / No | Qualitative |
116 | Improved environmental quality and sustainability | ( | Yes / No | Qualitative |
117 | Reduced emissions; regeneration or arrested degradation of natural resources | ( | Yes / No | Mixed |
118 | Improved awareness of environmental impacts and legislation for protection | ( | Yes / No | Qualitative |
119 | development of mitigation methods for reducing environmental hazards and losses from natural disasters | ( | Yes / No | Mixed |